CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 232 enrolled
Drug / intervention
Insufflation of carbon dioxide (CO2)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02330536
NCT02330536N/ACompleted

Cardiopulmonary Effects of Intrathoracic Pressure Overshoot During Carbon Dioxide Insufflation in Thoracoscopic Surgery

In Brief

A clinical study evaluating Insufflation of carbon dioxide (CO2) for Esophageal Neoplasms. Completed, enrolled 232 participants.

Detailed Summary

Video-assisted thoracoscopic surgery (VATS) has become a standard technique for addressing all types of thoracic pathology. Insufflation of carbon dioxide (CO2) into the operated chest cavity could increase lung collapse and improve surgical field view. The actual thoracic pressure values may not be identical with the presetting on the insufflator display. This overshoot pressure during VATS may compromise cardiac and pulmonary function. The purpose of this study is to evaluate the effects of intrathoracic pressure overshoot during two-lung ventilation on the hemodynamic and respiratory function and clarify the relative safety of two different techniques of insufflation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 5, 2015
Enrollment StartDec 1, 2014
Primary CompletionJul 1, 2020
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 11.5 years ago

Interventions

Insufflation of carbon dioxide (CO2)device

After patients were positioned, CO2 was insufflated into right pleural cavity at eight or twenty L/min. during video-assisted thoracoscopic surgery, thoracic pressure, hemodynamic and respiratory parameters were recorded.